Conn's Current Therapy 2025

**Selected for 2025 Doody’s Core Titles® with "Essential Purchase" designation in Family Medicine and General Internal Medicine**

Trusted by clinicians for more than 75 years, Conn’s Current Therapy presents today’s evidence-based information along with the personal experience and discernment of expert physicians. The 2025 edition is a helpful resource for a wide range of healthcare providers, including primary care physicians, subspecialists, and allied health professionals, providing current treatment information in a concise yet in-depth format. Nearly 350 topics have been carefully reviewed and updated to bring you state-of-the-art content in even the most rapidly changing areas of medicine.
• Offers personal approaches from recognized leaders in the field, covering common complaints, acute diseases, and chronic illnesses along with the most current evidence-based clinical management options• Follows a consistent, easy-to-use format throughout, with diagnosis, therapy, drug protocols, and treatment pearls presented in quick-reference boxes and tables for point-of-care answers to common clinical questions• Contains a new chapter on artificial intelligence, while extensively revised chapters with new author teams cover autism; constipation; depressive, bipolar and related mood disorders; medical toxicology; obsessive-compulsive disorder; osteoporosis; premenstrual syndrome; keloids; rosacea; and Q fever• Features thoroughly reviewed and updated information from multiple expert authors and editors, who offer a fresh perspective and their unique personal experience and judgment• Provides current drug information thoroughly reviewed by PharmDs• Features nearly 300 images, including algorithms, anatomical illustrations, and photographs, that provide useful information for management• An eBook version is included with purchase. The eBook allows you to access all of the text, figures, and references, with the ability to search, customize your content, make notes and highlights, and have content read aloud. Additional digital ancillary content may publish up to 6 weeks following the publication date